TickerFiles

BioAge Labs, Inc. 10-Q filing

Filed 2025-08-06 · Report date 2025-06-30 · 2025

View Original SEC Filing

Filing metadata

Accession number
0000950170-25-104176
Form type
10-Q
CIK
0001709941
Primary document
https://www.sec.gov/Archives/edgar/data/1709941/000095017025104176/bioa-20250630.htm

Extracted primary information

This filing includes deterministic financial metrics extracted from public filing data for BioAge Labs, Inc..

Reported financial metrics

MetricCurrentPriorChange
Total Assets$322.1M--
Revenue$3.9M--
Operating Income$-41.2M--
Net Income$-34.5M--
Eps Basic-0.96--
Eps Diluted-0.96--
Cash And Equivalents$220.3M--
Total Liabilities$27.4M--
Shareholders Equity$294.8M--
Operating Cash Flow$-37.3M--
Capital Expenditures$585,000--